NDC codes

404917 NDC codes with hospital pricing data in the network.

• NDC 49281-0725-10 — Influenza vaccine, 2025 season, for ages 9 and upAI (68 hospitals, 149–284 samples)
• NDC 45802-0040-64 — Selenium sulfide 2.5% lotionAI (450 hospitals, 247–283 samples)
• NDC 71266-9070-02 — Ketamine injection, 50 mg per mLAI (139 hospitals, 202–283 samples)
• NDC 10019-0873-15 — UNCLASSIFIED DRUGS (8 hospitals, 40–283 samples)
• NDC 50242-0077-01 — Herceptin Hylecta injection vialAI (494 hospitals, 211–283 samples)
• NDC 66215-0608-06 — Selexipag 800 mcg tablets, 60-count bottleAI (191 hospitals, 247–283 samples)
• NDC 71288-0414-91 — Glycopyrrolate 0.2 mg/mL injectionAI (26 hospitals, 130–283 samples)
• NDC 67877-0754-60 — Dronabinol 5 mg oral capsulesAI (311 hospitals, 156–282 samples)
• NDC 68462-0621-54 — Fosphenytoin sodium injection, 100 mg per 2 mLAI (247 hospitals, 183–282 samples)
• NDC 12496-0300-01 — Buprenorphine injection syringeAI (250 hospitals, 165–282 samples)
• NDC 83257-0004-12 — Trastuzumab-dkst intravenous infusion, 420 mgAI (414 hospitals, 165–282 samples)
• NDC 63323-0012-02 — Oxytocin injection, 10 units per mLAI (126 hospitals, 39–282 samples)
• NDC 16571-0786-01 — Lamotrigine 25 mg chewable tabletAI (106 hospitals, 228–282 samples)
• NDC 62484-0020-01 — Mercaptopurine 20 mg/mL oral liquidAI (118 hospitals, 183–282 samples)
• NDC 3877932445 — PYRIDOXINE 25 MG/ML ENTERAL LIQUID CMPD (9 hospitals, 282 samples)
• NDC 81565-0203-02 — Heparin irrigation solutionAI (18 hospitals, 282 samples)
• NDC 00088222033A — LANTUS INS 100UNIT/MI PE MDV (2 hospitals, 228–282 samples)
• NDC 73013-4001-01 — Ropivacaine 0.1% saline solutionAI (10 hospitals, 282 samples)
• NDC 62991-2189-03 — AZATHIOPRINE 50 MG/ML ENTERAL LIQUID CMPD (9 hospitals, 282 samples)
• NDC 00409-0829-01 — Aztreonam 1 gram injectionAI (275 hospitals, 65–281 samples)
• NDC 58160-0812-43 — Diphtheria, tetanus, pertussis and polio vaccine syringeAI (157 hospitals, 146–281 samples)
• NDC 63323-0401-24 — Aztreonam 1 gram injection solutionAI (195 hospitals, 65–281 samples)
• NDC 00069-0306-01 — Trastuzumab-qyyp 420 mg intravenous cancer drugAI (206 hospitals, 209–281 samples)
• NDC 63323-0402-41 — Aztreonam 2 gram injectionAI (109 hospitals, 65–281 samples)
• NDC 00409-0829-11 — Aztreonam 1 g injection powderAI (337 hospitals, 65–281 samples)
• NDC 63323-0401-41 — Aztreonam 1 gram injectionAI (112 hospitals, 65–281 samples)
• NDC 17156-0251-08 — Indium-111 pentetate injection (imaging agent)AI (321 hospitals, 38–281 samples)
• NDC 00338-9542-03 — NaCl 0.9% 500 mL bag inj. (6 hospitals, 227–281 samples)
• NDC 00641608025A — INJECTION, ONDANSETRON HYDROCHLORIDE, PER 1 MG (2 hospitals, 209–281 samples)
• NDC 25021-0113-82 — Fluconazole in saline IV solutionAI (173 hospitals, 28–280 samples)
• NDC 25021-0460-01 — Desmopressin acetate injection, 4 mcg/mLAI (241 hospitals, 28–280 samples)
• NDC 67066-0005-01 — Secretin injection, 16 mcg vialAI (598 hospitals, 127–280 samples)
• NDC 00378-2046-01 — Tacrolimus 1 mg immediate-release capsuleAI (132 hospitals, 127–280 samples)
• NDC 00517-4002-25 — Papaverine hydrochloride 30 mg/mL injectionAI (826 hospitals, 127–280 samples)
• NDC 00641-1398-31 — Chlorpromazine hydrochloride injection 50 mg/2 mLAI (492 hospitals, 28–280 samples)
• NDC 00003-7733-99 — Cefepime injection, 500 mgAI (18 hospitals, 28–280 samples)
• NDC 63833-0615-02 — Antihemophilic factor (factor VIII) vialAI (729 hospitals, 127–280 samples)
• NDC 43598-0914-06 — Vasopressin 20 units/mL IV solutionAI (203 hospitals, 28–280 samples)
• NDC 72888-0183-30 — Buprenorphine 8 mg dissolving tabletAI (50 hospitals, 28–280 samples)
• NDC 0469087120 — Adenosine intravenous solution for diagnostic testingAI (21 hospitals, 28–280 samples)
• NDC 0469087130 — Adenosine injection for diagnostic testingAI (21 hospitals, 28–280 samples)
• NDC 0641611310 — Adenosine injection for cardiac catheterizationAI (20 hospitals, 28–280 samples)
• NDC 0703877601 — Adenosine intravenous solution for diagnostic testingAI (29 hospitals, 28–280 samples)
• NDC 0703877701 — Adenosine intravenous solution for diagnostic testingAI (23 hospitals, 28–280 samples)
• NDC 1671497201 — Adenosine intravenous solution (diagnostic use)AI (20 hospitals, 28–280 samples)
• NDC 1671499701 — Adenosine injection for diagnostic testingAI (40 hospitals, 28–280 samples)
• NDC 2315525831 — Adenosine injection for heart imaging testingAI (44 hospitals, 28–280 samples)
• NDC 2502130720 — Adenosine injection (diagnostic), 3 mg/mLAI (20 hospitals, 28–280 samples)
• NDC 2502130730 — Adenosine injection for diagnostic testingAI (20 hospitals, 28–280 samples)
• NDC 5515019201 — Adenosine injection for diagnostic testingAI (56 hospitals, 28–280 samples)